This document discusses ocular drug delivery systems. It begins with an overview of eye anatomy and then introduces various ocular drug delivery formulations including solutions, suspensions, ointments, emulsions, and gels. It describes the advantages of controlled delivery systems for ocular drugs in increasing bioavailability and residence time. Various controlled delivery technologies are classified and evaluated, with examples like inserts, shields, and iontophoresis. Emerging areas like carbon nanotubes, pseudolatices, and vesicular systems are presented. The document concludes that controlled delivery can improve treatment effectiveness but that devices need further development for patient comfort.
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
Conventional ocular drug delivery system i.e., eye drops, ointments, gels etc., had become less popular pertaining to their disadvantages like evaporation by tears, pre-corneal loss, drug metabolism, drug-protein interaction, drainage, sticking of eye lids, induced lacrimation, poor patient compliance, systemic side effect and blurred vision etc. That’s why fundamentals of controlled release by means of ocular inserts were utilized to increase problem pre-corneal drug residence time.
This project title “Formulation and Evaluation of Ocuserts of Ciprofloxacin HCl” revealed following results:
Compatibility study using FTIR was performed to check the compatibility of drug with various excipient. Characteristics peaks obtained with pure drug were compared with that produced with different excipients that confirmed the compatibility of drug with excipients.
Ocusert of Ciprofloxacin HCl was prepared using different material i.e., PVP K-30, PVA, PEG 400 and glycerin.
Prepared ocuserts were evaluated for various parameters viz., percentage moisture loss, percentage moisture absorbs, thickness, weight variation, drug content and In-vitro diffusion.
The percentage (%) moisture absorption and loss of ocular insert were found to be 26% and 27% respectively.
The thickness of ocular insert was found to be uniformed and its mean while measuring at different points was found to be 0.124mm.
The weight of ocular inserts was found to be in the range of 12.2 - 12.6mg which indicated decent distribution of the drug, polymer and plasticizer.
The drug content of ocular insert was found to be 99.89%.
Percentage drug release from Ciprofloxacin HCl Ocusert was found to be 41.969% in 8 hr.
It was concluded that prepared Ocusert of Ciprofloxacin HCl could be a better alternative to conventional ocular formulations that retained on ocular surface for longer duration and released drug in controlled manner.
The presentation includes Introduction to Ocular Drug Delivery System, Anatomy of Human eye, Mechanism of Ocular Drug Absorption, Barriers for Ocular Delivery, Factors affecting Intraocular bioavailability, Drawbacks of traditional ophthalmic formulations, Classification of Ocular Drug Delivery System, Formulations of Ocular Drug Delivery System and Evaluation parameters of Ocular Drug Delivery System.
Contents
Introduction
Objective
Anatomy of the Eye
Routes of drug delivery of the eye
Mechanism of ocular absorption
Factors affecting intra-ocular bioavailability
Barriers of ocular drug absorption
Methods to overcome drug barriers
Evaluation
Conclusion
Reference
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases.
Applied topically to the cornea, or instilled in the space between the eyeball and lower eyelid
Definition: Ocular DDS are designed to instilled on to topical or intra-ocular or peri-ocular to eye.
Most commonly used ocular dosage forms-
- Solutions
- Suspensions
- ointments
Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
FORMULATION AND EVALUATION OF OCUSERTS OF CIPROFLOXACIN HClMohammad Adil
Conventional ocular drug delivery system i.e., eye drops, ointments, gels etc., had become less popular pertaining to their disadvantages like evaporation by tears, pre-corneal loss, drug metabolism, drug-protein interaction, drainage, sticking of eye lids, induced lacrimation, poor patient compliance, systemic side effect and blurred vision etc. That’s why fundamentals of controlled release by means of ocular inserts were utilized to increase problem pre-corneal drug residence time.
This project title “Formulation and Evaluation of Ocuserts of Ciprofloxacin HCl” revealed following results:
Compatibility study using FTIR was performed to check the compatibility of drug with various excipient. Characteristics peaks obtained with pure drug were compared with that produced with different excipients that confirmed the compatibility of drug with excipients.
Ocusert of Ciprofloxacin HCl was prepared using different material i.e., PVP K-30, PVA, PEG 400 and glycerin.
Prepared ocuserts were evaluated for various parameters viz., percentage moisture loss, percentage moisture absorbs, thickness, weight variation, drug content and In-vitro diffusion.
The percentage (%) moisture absorption and loss of ocular insert were found to be 26% and 27% respectively.
The thickness of ocular insert was found to be uniformed and its mean while measuring at different points was found to be 0.124mm.
The weight of ocular inserts was found to be in the range of 12.2 - 12.6mg which indicated decent distribution of the drug, polymer and plasticizer.
The drug content of ocular insert was found to be 99.89%.
Percentage drug release from Ciprofloxacin HCl Ocusert was found to be 41.969% in 8 hr.
It was concluded that prepared Ocusert of Ciprofloxacin HCl could be a better alternative to conventional ocular formulations that retained on ocular surface for longer duration and released drug in controlled manner.
The presentation includes Introduction to Ocular Drug Delivery System, Anatomy of Human eye, Mechanism of Ocular Drug Absorption, Barriers for Ocular Delivery, Factors affecting Intraocular bioavailability, Drawbacks of traditional ophthalmic formulations, Classification of Ocular Drug Delivery System, Formulations of Ocular Drug Delivery System and Evaluation parameters of Ocular Drug Delivery System.
Contents
Introduction
Objective
Anatomy of the Eye
Routes of drug delivery of the eye
Mechanism of ocular absorption
Factors affecting intra-ocular bioavailability
Barriers of ocular drug absorption
Methods to overcome drug barriers
Evaluation
Conclusion
Reference
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases.
Applied topically to the cornea, or instilled in the space between the eyeball and lower eyelid
Definition: Ocular DDS are designed to instilled on to topical or intra-ocular or peri-ocular to eye.
Most commonly used ocular dosage forms-
- Solutions
- Suspensions
- ointments
Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
TYPES OF OPTHALMIC PRODUCTS
Eye drops - Ophthalmic drops (eye drops) are sterile aqueous or oily solutions, suspensions, or emulsions intended for instillation into the conjunctival sac. Ophthalmic drops are considered isotonic when the tonicity is equal to that of a 0.9% solution of sodium chloride.
Eye lotion – Eye lotions are the aqueous solutions used for washing the eyes. The eye lotions are supplied in concentrated form and are required to be diluted with warm water immediately before use.
v
Eye Ointments - Ophthalmic ointments are sterile, homogeneous, semi-solid preparations intended for application to the conjunctiva or the eyelids. They are
Ocular drug delivery system is a method to deliver drugs to the eye to treat various eye conditions. This includes eye drops, ointments, and implants, which are designed to improve drug efficacy, minimize side effects, and provide sustained drug release. It is an important area of research and development in the field of ophthalmology, as it enables targeted and effective treatment of eye diseases. Here we have discussed about various preparations along with their evaluation parameters.
INTRODUCTION :
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases.
Eye is the most easily accessible site for topical administration of a medication.
Ideal ophthalmic drug delivery must be able to sustain the drug release and to remain in the vicinity of front of the eye for prolong period of time.
The bioavailability of ophthalmic drugs is very poor due to efficient protective mechanisms of the eye.
Blinking, reflex lachrymation, and drainage rapidly remove drugs, from the surface of the eye.
To overcome these, two approaches can be followed.
The first involves using alternate delivery routes to conventional ones allowing for more direct access to intended target sites.
Second approach involves development of novel drug delivery systems providing better permeability, treatability and controlled release at target site.
Combination of both these approaches are being utilized and optimized in order to achieve optimal therapy with minimal adverse effects.
They are specialized dosage forms designed to be instilled onto the external surface of the eye(topical), administered inside(intraocular) or adjacent(periocular) to the eye, or used in conjunction with an ophthalmic device.
The novel approach of drug delivery system in which drug can instill on the cull de sac cavity of the eye is known as ocular drug delivery system.
APPROACHES TO IMPROVE OCULAR DRUG DELIVERY:
Viscosity enhancer
Eye ointments
Prodrugs
Penetration enhancer
Mucoadhesives
In-situ gel
Nanoemulsion
Implants
Microemulsion
Liposomes
Niosomes
Nanoparticles
In the area of topical ocular administration, important efforts concern the design and the conception of new ophthalmic drug delivery systems able to prolong the residence time.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Ocular drug delivery system
1. Presented by:-
Sujit R. Patel,
Dept. of Pharmaceutics,
Maratha Mandal College Of Pharmacy,
Belgaum-590 010.
2. Contents:-
Anatomy of eye
Introduction
Advantages
Disadvantages
Classification
Evaluation of ocular drug delivery system
Future trends
Conclusion
February 11, 2013 Dept. Of Pharmaceutics 2
3. Anatomy of the Eye:-
February 11, 2013 Dept. Of Pharmaceutics 3
4. INTRODUCTION:-
Ophthalmic preparation
Applied topically to the cornea, or instilled in the
space between the eyeball and lower eyelid
Solution
• Dilutes with tear and wash away through lachrymal
apparatus
• Administer at frequent intervals
Suspension
• Longer contact time
• Irritation potential due to the particle size of drug
Ointment
• Longer contact time and greater storage stability
• Producing film over the eye and blurring vision
February 11, 2013 Dept. Of Pharmaceutics 4
5. Contd. . .
Emulsions
• Prolonged release of drug from vehicle but blurred
vision, patient non compliance and oil entrapment
are the drawbacks.
Gels
• Comfortable, less blurred vision but the drawbacks
are matted eyelids and no rate control on diffusion.
February 11, 2013 Dept. Of Pharmaceutics 5
6. Controlled delivery system
– Release at a constant rate for a long time
– Enhanced corneal absorption
– Drug with not serious side effect or tolerate by the
patient
February 11, 2013 Dept. Of Pharmaceutics 6
7. ADVANTAGES:-
Increase ocular residence, hence improving bioavailability.
Possibility of providing a prolonged drug release and thus a
better efficacy.
Increased shelf life with respect to aqueous solutions.
Exclusion of preservatives, thus reducing the risk of
sensitivity reactions as compare to aqueous solutions.
February 11, 2013 Dept. Of Pharmaceutics 7
8. Contd...
Possibility of targeting internal ocular tissue through non-
corneal routes.
Reduction of systemic side effects and thus reduced adverse
effects in case of topical application.
Reduction in the number of doses administration and thus
better patient compliance.
Administration of an accurate dose in the eye, which is fully
retained at the administration site, thus a better therapy.
February 11, 2013 Dept. Of Pharmaceutics 8
9. DISADVANTAGES:-
It is Expensive.
Insertion technique is difficult & expulsion of shields may
occur not individually fit for each patient.
Shields are not fully transparent & thus reduce visual activity.
Occasional inadvertent loss.
Difficult to handle.
Foreign body sensation.
February 11, 2013 Dept. Of Pharmaceutics 9
10. CLASSIFICATION OF COTROLLED
RELEASE OCULAR DRUG DELIVERY
SYSTEMS:-
Mucoadhesive/Bioadhesive dosage forms
Ocular inserts
Collagen shield
Drug presoaked hydrogel type lens and pledges
Ocular iontophoresis
Polymeric solutions
February 11, 2013 Dept. Of Pharmaceutics 10
11. Contd…
Pseudolatices
Ocular penetration enhancers
Phase transition systems
Particulate system like, microspheres and
nanoparticles
Vesicular systems like liposomes, niosomes,
phamacosomes and discomes
Chemical delivery system for ocular drug
targeting
February 11, 2013 Dept. Of Pharmaceutics 11
12. EVALUATION OF OCULAR
DRUG DELIVERY SYSTEM
February 11, 2013 Dept. Of Pharmaceutics 12
13. THICKNESS OF THE FILM :-
• Measured by Dial Caliper at different points and the
mean value is calculated.
DRUG CONTENT UNIFORMITY :-
• The cast film cut at different places and tested for drug
as per monograph.
UNIFORMITY OF WEIGHT :-
• Here, three patches are weighed.
February 11, 2013 Dept. Of Pharmaceutics 13
14. PERCENTAGE MOISTURE ABSORPTION :-
• Here, ocular films are weighed and placed in a
dessicator containing 100 ml of saturated
solution of Aluminium Chloride and 79.5%
humidity was maintained.
• After three days the ocular films are reweighed
and the percentage moisture absorbed is
calculated using the formula –
Final weight – Initial weight x 100
% moisture absorbed = Initial weight
February 11, 2013 Dept. Of Pharmaceutics 14
15. PERCENTAGE MOISTURE LOSS:-
• Ocular films are weighed and kept in a
dessicator containing anhydrous Calcium
Chloride.
• After three days, the films are reweighed and
the percentage moisture loss is calculated
using formula –
Initial weight – Final weight x 100
% moisture loss = Initial weight
February 11, 2013 Dept. Of Pharmaceutics 15
16. IN VITRO EVALUATION METHODS:-
BOTTLE METHOD
In this, dosage forms are placed in the bottle
containing dissolution medium maintained at
specified temperature and pH.
The bottle is then shaken.
A sample of medium is taken out at appropriate
intervals and analyzed for drug content.
February 11, 2013 Dept. Of Pharmaceutics 16
17. DIFFUSION METHOD
Here ocular film is placed between the donor and
receptor compartment.
Drug diffused from donor compartment to receptor
compartment containing buffer solution is
measured at various time intervals.
MODIFIED ROTATING BASKET METHOD
Dosage form is placed in a basket assembly
connected to a stirrer.
The assembly is lowered into a jacketed beaker
containing buffer medium and temperature 37 °C.
Samples are taken at appropriate time intervals and
analyzed for drug content.
February 11, 2013 Dept. Of Pharmaceutics 17
18. MODIFIED ROTATING PADDLE APPRATUS
Here, dosage form is placed in a diffusion cell
which is placed in the flask of rotating paddle
apparatus.
The buffer medium is placed in the flask and
paddle is rotated at 50 rpm.
The entire unit is maintained at 37 °C.
Aliquots of sample are removed at appropriate
time intervals and analyzed for drug content.
February 11, 2013 Dept. Of Pharmaceutics 18
19. IN VIVO DRUG RELEASE RATE STUDY:-
Here, the dosage form is applied to one eye of
animals and the other eye serves as control.
Then the dosage form is removed carefully at
regular time interval and are analyzed for drug
content.
The drug remaining is subtracted from the initial
drug content, which will give the amount of drug
absorbed in the eye of animal at particular time.
After one week of washed period, the
experiment was repeated for two times as before.
19
20. ACCELERATED STBILITY STUDIES:-
These are carried out to predict the breakdown
that may occur over prolonged periods of
storage at normal shelf condition.
Here, the dosage form is kept at elevated
temperature or humidity or intensity of light, or
oxygen.
Then after regular intervals of time sample is
taken and analyzed for drug content.
From these results, graphical data treatment is
plotted and shelf life and expiry date are
determined.
February 11, 2013 Dept. Of Pharmaceutics 20
23. Carbon nanotube:-
Carbon nanotubes are made up of graphite.
Its name is derived from its size, since the
diameter of a nanotube is in the order of a few
nanometers (approximately 1/50,000th of the
width of a human hair), while they can be up to
several millimeters in length.
February 11, 2013 Dept. Of Pharmaceutics 23
24. 3D structure of Carbon nanotube
February 11, 2013 Dept. Of Pharmaceutics 24
27. Pseudolatices:-
• Organic solution of polymers is dispersed in an aqueous phase to form O/W
emulsion
• The pseudolatex-based ocular formulations of Pilocarpine were prepared
using different combinations of Eudragit RS 100 and Polyvinyl Pyrrolidone
(PVP)for prolonged and controlled release of the drug.
• Water is removed partially to an extent that residual water is removed
sufficient enough to keep polymeric phase discrete & dispersed
• On application leave an intact noninvasive continuous polymer film which
reserves drugs
• Drug released slowly over prolonged period of time , better ocular
bioavailability patient compliance
27
28. Microspheres & Nanoparticles:-
• The drugs are bound to small particles which are then
dispensed in aqueous vehicles
• Nanoparticles of polybutylcyanoacrylate have been
used for human being as a drug carrier
• Pilocarpine nitrate loaded egg albumin microspheres
were prepared by thermal denaturation process in the
size range of 1-12 μm.
28
29. Ocular Iontophoresis:-
It is the process in which the direct current drives ions into cells or
tissues
Types:-
I. Trans-corneal
II. Trans- scleral
Antibiotics, Antifungal(e.g. Natamycin), Anesthetics(e.g. Benoxinate)
and Adrenergic(e.g. Timolol) are delivered by this method
29
32. Vesicular System:-
• Liposomes : Phospholipid-lipid vesicles
• Niosomes : Vesicles based on some non-ionic surfactants like dialkyl
polyoxyethylene ethers
• Phamacosomes : Pharmacosomes are amphiphilic phospholipid
complexes of drugs bearing active hydrogen that bind to phospholipids.
Pharmacosomes impart better biopharmaceutical properties to the drug,
resulting in improved bioavailability. Pharmacosomes have been prepared
for various non-steroidal anti-inflammatory drugs, proteins, cardiovascular
and antineoplastic drugs. Developing the pharmacosomes of the drugs has
been found to improve the absorption and minimize the gastrointestinal
toxicity.
• Discosomes : Systems formed by addition of specific amount of surfactant
to vesicular dispersions consisting of mixed vesicular and micelle regions
32
34. Continuous delivery system based
upon the osmotic property:-
Implantable mini-pump such as Alzet is the
example of such system.
Such system is placed beneath the skin of
the scalp.
To deliver the drug to the eye, the pump is
connected to the upper fornix by means of
polyethylene tubing.
February 11, 2013 Dept. Of Pharmaceutics 34
35. Contd. . .
Delivery of diethyl carbamazine in ocular
onchocerciasis
February 11, 2013 Dept. Of Pharmaceutics 35
37. Controlled ocular drug delivery systems increase the
efficiency of the drug by reducing its wastage and by
enhancing absorption by increasing contact time of
drug to the absorbing surface.
They improve patient compliance by reducing the
frequency of dosing.
They reduces the dose and thereby reduces the
adverse effects of the drug.
February 11, 2013 Dept. Of Pharmaceutics 37
38. Contd. . .
Although controlled release devices could be more
useful in the management of many ophthalmic
conditions, they are not very much popular because
such devices have to be put in place and taken out
from under the eyelid periodically.
Moreover, the devices can move around in the
precorneal space resulting in discomfort and visual
disturbances.
February 11, 2013 Dept. Of Pharmaceutics 38
39. References :-
1. Controlled drug delivery – Concepts and Advances, by S.P. Vyas
and Roop K. Khar.
2. Ansel’s Pharmaceutical dosage forms and drug delivery systems,
by Loyd V. Allen, Nicholas G. Popovich and Howard c. Ansel.
3. Advances in Controlled and Novel drug delivery, edited by N.K.
Jain.
4. Textbook of Industrial Pharmacy, edited by Shobharani R.
Hiremath.
5. Novel drug delivery systems, by Y.W. Chein, published by
Marcel Dekker, volume 50.
6. http://google.co.in Crystalsert Crystalens Delivery System - YouTube.flv
7. http://youtube.com
EndoSerter MDEA Finalist 2012 - YouTube.flv
February 11, 2013 Dept. Of Pharmaceutics 39
40. Important Questions:-
20 Marks
1) What are the causes of poor drug availability from conventional
ophthalmic preparations? Explain design, mechanism and adv of
ocuserts? [2005]
2) Give an account of ocular absorption, Give examples of controlled
release products for ocular route?[2002]
3)
a) Explain different methods for formulating ocular controlled drug
delivery systems?
b) Explain different methods for formulating ocular controlled drug
delivery systems?[2001]
February 11, 2013 Dept. Of Pharmaceutics 40
41. 10 Marks
1)Bring out the specific advantages & disadvantages ocuserts
systems for ocular drug delivery? sketch a neat blow up diagram of
ocusert diagram of “ocusert”?[2004]
2)Explain the formulation of ocuserts?[2006]
3)Explain the drug release pattern of ophthalmic inserts ?[2006]
4)Giving the disadvantages of ophthalmic formulations .write a note
on ocusert?[2007]
5)How do you design and manufacture ocuserts?[2008]
February 11, 2013 Dept. Of Pharmaceutics 41
42. o u
Y
n k
h a
T
February 11, 2013 Dept. Of Pharmaceutics 42